
Prozomix is a biotechnology company specializing in the discovery, development, and supply of a large and diverse range of proprietary biocatalysts and enzymes. It offers a free-to-use Biocatalysis Enzyme Toolkit with over 4000 enzymes for commercial screening, focusing on maximum diversity from proprietary metagenomic data. Prozomix serves 17 of the largest 20 pharmaceutical companies globally, providing rapid, flexible, and cost-effective enzyme solutions with short lead times and freedom to operate under the Nagoya Protocol. The company also collaborates with Ginkgo Bioworks to develop next-generation AI-designed enzymes, enhancing enzyme optimization and application. Prozomix operates manufacturing facilities with pilot and production plants, producing enzymes at scales up to multi-kilogram batches, and has a strong R&D foundation driven by its proprietary GRASP™ technology. It is committed to sustainability, exemplified by its solar power initiatives and marine biodiversity sampling expeditions.

Prozomix is a biotechnology company specializing in the discovery, development, and supply of a large and diverse range of proprietary biocatalysts and enzymes. It offers a free-to-use Biocatalysis Enzyme Toolkit with over 4000 enzymes for commercial screening, focusing on maximum diversity from proprietary metagenomic data. Prozomix serves 17 of the largest 20 pharmaceutical companies globally, providing rapid, flexible, and cost-effective enzyme solutions with short lead times and freedom to operate under the Nagoya Protocol. The company also collaborates with Ginkgo Bioworks to develop next-generation AI-designed enzymes, enhancing enzyme optimization and application. Prozomix operates manufacturing facilities with pilot and production plants, producing enzymes at scales up to multi-kilogram batches, and has a strong R&D foundation driven by its proprietary GRASP™ technology. It is committed to sustainability, exemplified by its solar power initiatives and marine biodiversity sampling expeditions.